| Name | C-C motif chemokine 21 | ||
| UniProt ID | CCL21_HUMAN | ||
| Gene Name | CCL21 | ||
| Gene ID | 6366 | ||
| Synonyms |
CCL21, 6Ckine, CKb9, ECL, SCYA21, SLC, TCA4
|
||
| Sequence |
MAQSLALSLLILVLAFGIPRTQGSDGGAQDCCLKYSQRKIPAKVVRSYRKQEPSLGCSIP
AILFLPRKRSQAELCADPKELWVQQLMQHLDKTPSPQKPAQGCRKDRGASKTGKKGKGSK GCKRTERSQTPKGP |
||
| Pathway Map | MAP LINK | ||
| KEGG ID | hsa6366 | ||
| TTD ID | T93237 | ||
| Pfam | PF00048; PF20902 | ||
| Pair Name | Niacinamide, Gemcitabine | |||
| Phytochemical | Niacinamide | |||
| Drug | Gemcitabine | |||
| Disease Info | [ICD-11: 2C10] | Pancreatic cancer | Investigative | |
| Regulate Info | Up-regulation | C-C motif chemokine 21 | Expression | |
| Result | This study highlights the potential of NAM+GEM as immunotherapy for advanced pancreatic cancer. | |||
